Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2022
Reporting Period: This filing announces financial results for the three months ended September 30, 2022. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for the actual figures. Consequently, the following metrics are not available in this document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide comparative data or specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing serves solely to announce the issuance of a press release regarding Q3 2022 results. No specific commentary, guidance, or outlook is included in the text of this 8-K.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information contained herein and in the exhibits shall not be incorporated by reference into other filings unless expressly stated. It also notes that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) to obtain actual revenue, net income, and cash flow figures for the quarter ended September 30, 2022.
- Verify the Company's status as an emerging growth company and any associated accounting election impacts.
- Confirm the trading symbol INBS on The Nasdaq Stock Market LLC.
- Check for any subsequent filings that may incorporate the press release by reference.